Literature DB >> 9743993

The genetic basis of tuberous sclerosis.

J Young, S Povey.   

Abstract

Tuberous sclerosis is a relatively common inherited disease that causes multiple benign tumours in different organs, frequently leading to skin rashes, seizures and mental handicap. The disease can be caused by mutations in either of two genes, TSC2, identified in 1993, and TSC1, only recently identified. Here we review the current state of knowledge of the molecular genetics of tuberous sclerosis and the spectrum of mutations seen in and the implications of recent findings for patients. Although both genes appear to function as tumour suppressors, the function of their protein products is not understood. A speculative model of how these proteins might function is briefly described.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9743993     DOI: 10.1016/s1357-4310(98)01245-3

Source DB:  PubMed          Journal:  Mol Med Today        ISSN: 1357-4310


  25 in total

1.  Irradiation exacerbates cortical cytopathology in the Eker rat model of tuberous sclerosis complex, but does not induce hyperexcitability.

Authors:  Naranzogt Tschuluun; H Jürgen Wenzel; Philip A Schwartzkroin
Journal:  Epilepsy Res       Date:  2006-09-29       Impact factor: 3.045

2.  Molecular mechanism of size control in development and human diseases.

Authors:  Xiaolong Yang; Tian Xu
Journal:  Cell Res       Date:  2011-04-12       Impact factor: 25.617

3.  Tuberous sclerosis complex: diagnostic challenges, presenting symptoms, and commonly missed signs.

Authors:  Brigid A Staley; Emily A Vail; Elizabeth A Thiele
Journal:  Pediatrics       Date:  2010-12-20       Impact factor: 7.124

4.  Lethality of Drosophila lacking TSC tumor suppressor function rescued by reducing dS6K signaling.

Authors:  Thomas Radimerski; Jacques Montagne; Maja Hemmings-Mieszczak; George Thomas
Journal:  Genes Dev       Date:  2002-10-15       Impact factor: 11.361

5.  TSC1 and TSC2 tumor suppressors antagonize insulin signaling in cell growth.

Authors:  X Gao; D Pan
Journal:  Genes Dev       Date:  2001-06-01       Impact factor: 11.361

6.  Computational Systems Bioinformatics and Bioimaging for Pathway Analysis and Drug Screening.

Authors:  Xiaobo Zhou; Stephen T C Wong
Journal:  Proc IEEE Inst Electr Electron Eng       Date:  2008-08-01       Impact factor: 10.961

7.  The methylation of the TSC2 promoter underlies the abnormal growth of TSC2 angiomyolipoma-derived smooth muscle cells.

Authors:  Elena Lesma; Silvia Maria Sirchia; Silvia Ancona; Stephana Carelli; Silvano Bosari; Filippo Ghelma; Emanuele Montanari; Anna Maria Di Giulio; Alfredo Gorio
Journal:  Am J Pathol       Date:  2009-05-14       Impact factor: 4.307

8.  Biochemical and functional characterizations of small GTPase Rheb and TSC2 GAP activity.

Authors:  Yong Li; Ken Inoki; Kun-Liang Guan
Journal:  Mol Cell Biol       Date:  2004-09       Impact factor: 4.272

9.  Survivin expression in tuberous sclerosis complex cells.

Authors:  Stephana Carelli; Elena Lesma; Simona Paratore; Vera Grande; Giorgia Zadra; Silvano Bosari; Anna Maria Di Giulio; Alfredo Gorio
Journal:  Mol Med       Date:  2007 Mar-Apr       Impact factor: 6.354

10.  Regulation of the TSC pathway by LKB1: evidence of a molecular link between tuberous sclerosis complex and Peutz-Jeghers syndrome.

Authors:  Michael N Corradetti; Ken Inoki; Nabeel Bardeesy; Ronald A DePinho; Kun-Liang Guan
Journal:  Genes Dev       Date:  2004-07-01       Impact factor: 11.361

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.